Drugs For Tuberculosis Flashcards
Mycobacteria:
( aerobic or anaerobic?) , bacillary type bacteria that grow like _____ (___) and belong to the genus ___________ (Mycobacteriaceae)
Aerobic
fungus; Myco
Actinobacteria
Mycobacteria
They have (thinner or thicker?) cell wall than many other bacteria.
Their cell wall is _____, ______phobic and contain _______ as well as large amount of ________ which is responsible for their __________
.
Thicker
waxy; hydro; peptidoglycan
mycolic acid
acid fastness.
Mycobacteria consist of many species and many pathogens including those that cause _________ and ______
leprosy and tuberculosis.
Mycobacteria infections (MI) Types:
•
– (a) __________ (_____) caused by ________
– (b)___________ (_____)
Tuberculosis (TB)
M. tuberculosis
Non-tuberculous MI
NTB
Mycobacteria infections (MI) Types:
Non-tuberculous MI (NTB):
_________
___________
Leprosy
Atypical MI
Atypical MI:
Those that cause _____ disease
Those that cause ___ disease
lung
skin
Atypical MI:
Those that cause lung disease: Mycobacterium ___________ and Mycobacterium ___________
avium-intracellulare and kansasii
Atypical MI:
Those that cause skin disease: M. ________ , M. _______, M. _____, M. ______ and M. _______
marinum; ulcerans; chelonae
fortuitum
abscessus
Manifestation
– TB: originates as ______ infections which spread to the ______, laryngeal, pharyngeal, ____,_____, and _______ spaces.
lung
cervical lymph nodes
oral, aural and ocular
Manifestation
– NTB: originates in ______,______,______, and ________
cervical lymph nodes, aural and ocular spaces.
Diagnosis:l of mycobacterium
(I) ______ and ______ tests to identify the specific type of bacteria present in the lungs
(ii)_______ to image the lungs
(iii)________ to view the lung’s airways
Blood and sputum
CT scans
Bronchoscopy
Mycobacteria infections (MI) Management:
– (a) Tuberculous: _______ anti-tuberculous chemotherapy
Systemic
Mycobacteria infections (MI) Management:
– (b) Non-tuberculous MI: ______ + ______ + ____ until _____ culture is negative for _________
Azithromycin
ethambutol
rifampin
monthly; year
Mycobacteria infections (MI)
Transmission:
TB: transmitted via _____ of infected aerosols generated by active TB patients when he _________________________
inhalation
coughs, sneezes, laughs, spits or talks
Tuberculosis :Types
_______ TB
________TB
___________(MDR-TB)
____________________ (XDR-TB)
___________ tuberculosis
Latent
Active
Multidrug resistant tuberculosis
Extensively multidrug resistant tuberculosis
Extra-pulmonary
Tuberculosis (TB)
Latent TB: Occurs when the bacteria is _____________________. And _____________.
in the body without the person developing symptoms
cannot infect others.
Tuberculosis (TB)
Active TB: Occurs when the bacteria is ___________________.
Person with active TB can _________
in the body and the person is having symptoms
infect others.
Tuberculosis (TB)
Multidrug resistant tuberculosis (MDR-TB): TB that is ________________________ ( ______ and ________ ).
resistant to the two most potent first line drugs
isoniazid and rifampin
Tuberculosis (TB)
Extensively multidrug resistant tuberculosis (XDR-TB): TB infection that is _________________ and, at least, _______________________ ( _____,_______,______), and any of the __________ .
resistant to rifampin, isoniazid
one of the three injectable second-line drugs
Amikacin, kanamycin or capreomycin
fluoroquinolones
Tuberculosis (TB)
Extra-pulmonary tuberculosis:
Tuberculosis _________ is called extra-pulmonary tuberculosis
not affecting the lungs
Signs and symptoms tuberculosis
o Latent TB: A person with latent TB will have ___ symptoms, and ____ damage will show on a chest X-ray
However, a _______ or _______ will indicate that they have TB infection
no; no
blood test or skin prick test
Signs and symptoms tuberculosis
o Active TB:
•a _______ lasting at least _______
•coughing ______ which may have _____ in it
•loss of appetite and weight, fatigue and being unwell
•swelling in the ____, fever, _______ , chest pain and chills.
persistent cough; 3 weeks
phlegm; blood
neck; night sweats
Signs and symptoms tuberculosis
Symptoms of ACTIVE TB typically ______ over time, but they can also _______ and ________
worsen
spontaneously go away and return.
Mycobacteria infection
Epidemiology: In 2019, Estimated __________ active TB global cases with _______ deaths were reported. And Nigeria (4.4%) ranked ______ behind ____ (26%), Indonesia (8.5%), China (8.4%), Philippines (6.0%) and Pakistan (5.7%) - (WHO, 2020).
10 million
1.4 million
6th; India
Tuberculosis : Prevention
•Getting a ______ and _________ early
•___________________________ until there is no longer a risk of infection
•wearing a _____, covering the _____, and _______ rooms
diagnosis and treatment
Staying away from other people
mask; mouth; ventilating
Tuberculosis : Prevention
TB vaccination: In some countries, children receive an anti-TB vaccination {the ___________ vaccine — as part of a regular immunization program}.
bacillus Calmette–Guérin (BCG)
Tuberculosis: Complications
_______: Without treatment
Death
Tuberculosis: Complications
Disseminated infection: If it spreads throughout the body, the infection can cause problems with the _______ system and _______ function.
cardiovascular
metabolic
Tuberculosis: Complications
_______: TB can also lead to this, a potentially life threatening form of infection.
Sepsis
Tuberculosis: Complications
________
__________
__________
Death
Disseminated infection
Sepsis
TB can be fatal
T/F
T
TB can lead to sepsis
T/F
T
Antituberculous drugs
First line agents :
List all 5
Isoniazid, Rifamycin, pyrazinamide, ethambutol and streptomycin.
Antituberculous drugs
Second line agents: are used when there is _________,_________, or __________ to _________
there is intolerance, drug resistance or contraindication to the first line agents.
Rifamycin (______,________ or _________ )
rifampin, rifabutin or rifapentine
Antituberculous drugs
Second line drugs: They include _______, Clofazimine, _______, Delamanid, ______,_________ (levofloxacin or moxifloxacin), Linezolid, ________ acid, Pretomanid, Thioacetazone and Injectable-only agents (______,_______, and ———— ), _______ plus _________
Bedaquiline
Cycloserine
Ethionamide
Fluoroquinolones
Para-aminosalicylic
Amikacin, kanamycin and capreomycin
Carbapenems; clavulanate
Isoniazid is a prodrug
T/F
T
Anti-TB. Drugs
Isoniazid: A synthetic derivative of _______
– Mechanism of action: Appears to ______________________, major components of the mycobacterial cell wall.
nicotinic acid
block the synthesis of mycolic acids
Isoniazid
Uses: Used with ______ for latent TB. And combined with ______,________ and either ———— or ________ for active TB.
Nothing
rifampicin, pyrazinamide and either ethambutol or streptomycin
Isoniazid
Adverse effects:
________ due to ______ depletion
___________ due to raised ______ and ____
nausea and vomiting
Blood ________
Peripheral neuritis; pyridoxine
Hepatotoxicity; ALT and AST
dyscrasia
Isoniazid is recommended in pregnancy.
T/F
F
Not recommended in pregnancy.
Antituberculous drugs
Rifampicin:
– Mechanism of action: It _________________
inhibits RNA synthesis